Skip to Main Content

Paper Details

US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.
JAMA Intern Med
4
2022
Author NameAffiliation
Sanket S Dhruvaand Philip R. Lee Institute of Health Policy Studies, University of California san francisco
  • 1 - 1

Datasets

Release 1.2